IP Library Granted Patent US 7,826,652
Granted Patent B2
US 7,826,652 · App. 11/613,166 · Granted Nov 2, 2010

Method for forming an optimally exposed image of cytological specimen

Assignee: Cytyc Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,826,652
App. No.
11/613,166
Granted
Nov 2, 2010
Kind
B2
Abstract

First and second images of respective portions of a cytological specimen are acquired at different brightness levels. Sections of the respective first image are selected and combined with selected sections of the second image of each portion to form a composite image, so that non-nuclei cytological components that would otherwise appear dark in a single exposure image are brighter in the composite image.

Claims (32)

1. A method of generating a substantially optimally exposed image of a cytological specimen, comprising:

acquiring a first image of the specimen at a first brightness level;

acquiring a second image of the specimen at a second brightness level higher than the first brightness level;

combining the respective sections of the first and second images to form a substantially optimally exposed image of the cytological specimen;

selecting sections of the first image which correspond to non-nuclei components of the cytological specimen acquired at the first brightness level; and

selecting sections of the second image corresponding to nuclei components of the cytological specimen acquired at the second brightness level.

2. The method of claim 1 , wherein the first and second images are obtained of substantially a same portion of the specimen, the specimen portion containing both nuclei and non-nuclei components of individual cells.

3. The method of claim 2 , wherein nuclei components of the individual cells are more distinct in the second image than in the first image.

4. The method of claim 2 , wherein non-nuclei components of the individual cells are more distinct in the first image than in the second image.

5. The method of claim 1 , wherein the first brightness level is based on a first exposure time, and the second brightness level is based on a second exposure time different than the first exposure time.

6. The method of claim 1 , wherein the second brightness level is about four times greater than the first brightness level.

7. The method of claim 1 , wherein the first brightness level is a non-saturation brightness level, and the second brightness level is a saturation brightness level.

8. The method of claim 1 , wherein the respective selected sections of the first and second images are combining by replacing pixels of the selected sections of one of the first and second images with pixels of the selected sections of the other one of the first and second images.

9. The method of claim 1 , wherein the respective selected sections of the first and second images are combining by merging pixels of the selected sections of the first image with pixels of the selected sections of the second image.

10. The method of claim 1 , further comprising generating a mask that includes pixels of the first image representing nuclei and non-nuclei components of the specimen.

11. The method of claim 10 , wherein the mask is generated by filtering and binarizing the first image, the mask including binary values representing both nuclei and non-nuclei cells components.

12. A method of generating a substantially optimally exposed image of a cytological specimen, comprising:

acquiring a first image of the specimen at a first brightness level;

acquiring a second image of the specimen at a second brightness level higher than the first brightness level; and

combining the respective sections of the first and second images to form a substantially optimally exposed image of the cytological specimen,

wherein the first image containing cell nuclei having a gray scale brightness value of approximately 20, non-nuclei cell components having a grayscale brightness value in a range of approximately 50-150, and background having a gray scale brightness of about 229, respectively, based on a gray scale brightness range of 0-255.

13. The method of claim 12 , the second image containing cell nuclei having a gray scale brightness value of approximately 80, and non-nuclei cell components and background that are saturated, respectively, based on the gray scale brightness range of 0-255.

14. A method of generating a substantially optimally exposed image of a cytological specimen, comprising:

acquiring a first image of a first portion of the specimen, the first image being acquired at a first brightness level;

acquiring a second image of the first portion of the cytological specimen, the second image being acquired at a second brightness level that is higher than the first brightness level;

selecting sections of the first image corresponding to non-nuclei components of the first portion of the specimen;

selecting sections of the second image corresponding to the nuclei components of the first portion of the specimen; and

combining the respective selected sections of the first and second images to form an substantially optimally exposed image of the first portion of the specimen.

15. The method of claim 14 , wherein the second brightness level is about four times higher than the first brightness level.

16. The method of claim 14 , wherein the first brightness level is a non-saturation brightness level, and the second brightness level is a saturation brightness level.

17. The method of claim 14 , wherein nuclei components of the individual cells are more distinct in the second image than in the first image, and wherein non-nuclei components of the individual cells are more distinct in the first image than in the second image.

18. The method of claim 14 , wherein the respective selected sections of each of the respective first and second images are combining by merging pixels of the selected sections of the first image with pixels of the selected sections of the second image.

Assignments (11)
RELEASE OF SECURITY INTEREST Recorded Apr 28, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: HOLOGIC, INC., ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO DIRECT RADIOGRAPHY CORP.; CYTYC CORPORATION, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO BIOLUCENT, LLC; CYTYC SURGICAL PRODUCTS, LLC, AS SUCCESSOR-BY-CONVERSION TO CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; GEN-PROBE INCORPORATED, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.
Reel/Frame 075566/0039 →
SECURITY INTEREST Recorded Apr 8, 2026
From: BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; CYTYC CORPORATION; SUROS SURGICAL SYSTEMS, INC.; GYNESONICS, INC.; BOLDER SURGICAL, LLC; FAXITRON BIOPTICS, LLC; HEALTH BEACONS, INC.; HOLOGIC, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 075462/0440 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 035820 FRAME: 0239. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST RELEASE. Recorded Nov 9, 2017
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 044727/0529 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 028810 FRAME: 0745. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT. Recorded Nov 9, 2017
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 044432/0565 →
SECURITY AGREEMENT Recorded Aug 7, 2015
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; DIRECT RADIOGRAPHY CORP.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 036307/0199 →
SECURITY INTEREST RELEASE REEL/FRAME 028810/0745 Recorded Jun 4, 2015
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 035820/0239 →
SECURITY AGREEMENT Recorded Aug 1, 2012
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 028810/0745 →
TERMINATION OF PATENT SECURITY AGREEMENTS AND RELEASE OF SECURITY INTERESTS Recorded Aug 26, 2010
From: GOLDMAN SACHS CREDIT PARTNERS, L.P., AS COLLATERAL AGENT
To: HOLOGIC, INC.; R2 TECHNOLOGY, INC.; SUROS SURGICAL SYSTEMS, INC.; BIOLUCENT, LLC; DIRECT RADIOGRAPHY CORP.; CYTYC SURGICAL PRODUCTS II LIMITED PARTNERSHIP; CYTYC SURGICAL PRODUCTS LIMITED PARTNERSHIP; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS III, INC.; CYTYC PRENATAL PRODUCTS CORP.; THIRD WAVE TECHNOLOGIES, INC.
Reel/Frame 024892/0001 →
PATENT SECURITY AGREEMENT Recorded Jul 29, 2008
From: CYTYC CORPORATION
To: GOLDMAN SACHS CREDIT PARTNERS L.P., AS COLLATERAL AGENT
Reel/Frame 021301/0879 →
PATENT SECURITY AGREEMENT Recorded Oct 26, 2007
From: CYTYC CORPORATION
To: GOLDMAN SACHS CREDIT PARTNERS L.P.
Reel/Frame 020018/0529 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 21, 2007
From: HUNT, BARRY
To: CYTYC CORPORATION
Reel/Frame 019042/0460 →
Continuity (1)
Related Publication 20080144898A1 · Jun 19, 2008